| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 25.328 | 43.919 | 55.067 | 63.654 | 77.786 | 70.532 | 95.166 | 106.360 |
| Total Income - EUR | - | - | 25.329 | 43.926 | 55.078 | 63.660 | 77.793 | 70.540 | 95.411 | 106.679 |
| Total Expenses - EUR | - | - | 9.197 | 18.656 | 19.187 | 16.978 | 21.013 | 26.408 | 26.938 | 22.038 |
| Gross Profit/Loss - EUR | - | - | 16.132 | 25.270 | 35.891 | 46.682 | 56.780 | 44.131 | 68.472 | 84.641 |
| Net Profit/Loss - EUR | - | - | 15.879 | 24.832 | 35.340 | 46.090 | 56.018 | 43.440 | 67.537 | 81.504 |
| Employees | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medforte Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 80 | 0 | 0 | 0 | 728 | 466 | 0 | 148.618 |
| Current Assets | - | - | 20.408 | 27.324 | 36.307 | 47.409 | 56.260 | 51.548 | 68.957 | 3.894 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 211 | 260 | 32.641 | 791 | 35.057 | 13.148 | 2.870 |
| Cash | - | - | 20.408 | 27.112 | 36.046 | 14.768 | 55.469 | 16.490 | 55.809 | 1.023 |
| Shareholders Funds | - | - | 15.923 | 24.884 | 35.391 | 46.140 | 56.066 | 43.489 | 67.586 | 81.553 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 4.566 | 2.439 | 916 | 1.270 | 922 | 8.525 | 1.371 | 70.959 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Medforte Srl